Mail

UK markets close in 3 hours 49 minutes

FTSE 100
8,234.58
+29.47(+0.36%)
FTSE 250
20,462.35
+81.30(+0.40%)
AIM
774.75
-2.75(-0.35%)
GBP/EUR
1.1832
-0.0002(-0.02%)
GBP/USD
1.2690
-0.0032(-0.25%)
Bitcoin GBP
52,209.35
+964.27(+1.88%)

Best UK mortgage deals of the week

Average two-year mortgage deal is now around 6%

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

13.28

+0.13

(+0.99%)

At close: 04:00PM EDT

13.49

+0.21

(+1.58%)

After hours:

04:44PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	796.39M
Enterprise value	488.31M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	20.29
Price/book (mrq)	2.79
Enterprise value/revenue	38.50
Enterprise value/EBITDA	-0.72

Trading information

Stock price history

Beta (5Y monthly)	1.85
52-week change ³	148.22%
S&P500 52-week change ³	25.22%
52-week high ³	30.96
52-week low ³	5.26
50-day moving average ³	15.50
200-day moving average ³	14.04

Share statistics

Avg vol (3-month) ³	809.78k
Avg vol (10-day) ³	799.59k
Shares outstanding ⁵	59.97M
Implied shares outstanding ⁶	59.97M
Float ⁸	42.89M
% held by insiders ¹	17.08%
% held by institutions ¹	61.51%
Shares short (15 May 2024) ⁴	6.12M
Short ratio (15 May 2024) ⁴	6.94
Short % of float (15 May 2024) ⁴	10.80%
Short % of shares outstanding (15 May 2024) ⁴	10.21%
Shares short (prior month 15 Apr 2024) ⁴	3.75M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	-1,977.16%

Management effectiveness

Return on assets (ttm)	-15.16%
Return on equity (ttm)	-154.98%

Income statement

Revenue (ttm)	12.68M
Revenue per share (ttm)	0.43
Quarterly revenue growth (yoy)	-56.50%
Gross profit (ttm)	N/A
EBITDA	-44.08M
Net income avi to common (ttm)	-232.03M
Diluted EPS (ttm)	-17.58
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	309.71M
Total cash per share (mrq)	5.16
Total debt (mrq)	1.62M
Total debt/equity (mrq)	0.57%
Current ratio (mrq)	10.18
Book value per share (mrq)	4.78

Cash flow statement

Operating cash flow (ttm)	-42.91M
Levered free cash flow (ttm)	-18.52M